The Lynx Group
Association for Value-Based Care
2020 Eddie Ozzie Award Winner
Winner of Folio's 2020
Eddie & Ozzie Awards

AVBCC 2020 Summit

No one truly knows what it is like to navigate cancer until they are diagnosed with the disease. In this session, survivors shared their stories and messages of hope as we prepare for Thanksgiving.
Read More

Depending on the stakeholder’s point of view, value-based contracting can have many definitions and meanings. In this session, experts from across the healthcare continuum explore what is working, what has failed, and what lessons have been learned regarding value-based contracting.
Read More

Designing and implementing value-based contracts is a challenge to stakeholders across the cancer care ecosystem. In this discussion, panelists analyze the future of these contracts and precision medicine.
Read More

During the COVID-19 pandemic, telehealth has been considered a silver lining in that it has allowed increased access to care. In this session, experts discuss the early challenges of telehealth and how it can improve the future of cancer care.
Read More

The COVID-19 pandemic has had many devastating effects beyond the spread of the disease, and these effects have led to important lessons in the healthcare system. In this session, experts discuss key takeaways from the pandemic and the future of cancer care in the new normal.
Read More

The COVID-19 pandemic has allowed telemedicine to be widely adopted for the delivery of cancer care. In this session, experts discuss some of the benefits of this technology, as well as key legal issues that need to be addressed.
Read More

Value-based contracts (VBCs) are the future of healthcare. However, many barriers to entry exist for the exploration of these contracts. In this discussion, experts offer legal perspectives on the goals of VBCs and potential hurdles and solutions.
Read More

As the COVID-19 pandemic continues, patients with cancer face numerous challenges. Healthcare professionals continue to play a critical role in advocating for their patients’ access to care.
Read More

In recent years, there has been an increase in the number of innovative treatments developed for the management of patients with cancer, including CAR T-cell therapies. In this session, experts from all facets of healthcare offered their perspectives on the use of these agents in the context of value-based care.
Read More

Virtual care, which has existed in the background of medicine for years, has now come to the forefront during the COVID-19 pandemic. Experts on telehealth weighed in on the impact of this technology on cancer care and what is on the horizon.
Read More

Page 3 of 5

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to receive the free VBCC print publication or weekly e‑Newsletter.

I'd like to receive: